Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
7.85    -0.25 (-3.03%)
Bid:
7.70
Ask:
8.00
Spread: 0.30 (3.896%)
Market Cap: £52.42m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Directorate Changes

16 Dec 2020 07:00

RNS Number : 7767I
Kromek Group PLC
16 December 2020
 

16 December 2020

 

Kromek Group plc

("Kromek" or the "Group")

 

Directorate Changes

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce the appointment of Mr Berry Beumer, Chief Operating Officer ("COO"), as an Executive Director of the Group with immediate effect. Furthermore, Mr Rakesh Sharma OBE, who joined the Group as a Non-executive Director in October 2020, will replace Sir Peter Williams CBE as Non-executive Chairman, who is retiring from the Board on 1 January 2021.

 

Mr Albertus ("Berry") Beumer, aged 56, is a technology business executive with extensive experience of delivering revenue growth in the analytical instrument, high-frequency communications equipment and optoelectronic and semiconductor materials industries. Since joining Kromek as COO in 2015, based in the Group's Pennsylvania facility, he has played an instrumental role in the growth of the business through the expansion of Kromek's US customer base and operations in both medical imaging and nuclear detection. Prior to Kromek, he held a number of senior roles at businesses in Europe and the US, including 14 years as Vice President, Sales and Marketing at XOS, Inc., part off Danaher Inc., a leading manufacturer of application-specific x-ray analysers, where he was responsible for driving the strategic direction of their x-ray elemental technology business.

 

Rakesh Sharma OBE, Chairman Designate of Kromek, said: "It is a great honour to succeed Sir Peter as Chairman. I thank him for his valuable contribution which has enabled Kromek to truly transform during his tenure, and we wish him all the best in his retirement. I am also pleased to welcome Berry to the Board. He has played a fundamental role in our growth as part of the executive team and we look froward to further benefitting from his expertise in his new role. Kromek is an ambitious company with advanced technology, extensive IP and a foothold in some of the most important markets today. We are excited about the future and delivering on our plans to secure sustainable growth and shareholder value."

 

Sir Peter Williams added: "It has been a pleasure to be a part of Kromek's journey as it has matured and scaled up over recent years into a truly international business with diversified revenue streams. As I retire, I leave the role of Chairman in the very capable hands of Rakesh who brings tremendous experience in overseeing the growth of international hi-tech engineering and manufacturing businesses. I also congratulate Berry Beumer on joining the Board and, following Paul Farquhar's recent appointment, I leave Kromek with a refreshed and powerful team at the helm under Arnab Basu's leadership. I will be following the business closely and look forward to watching its continued progress."

 

Mr Beumer holds 80,000 ordinary shares in the Group, representing 0.02% of the issued share capital. There are no other matters required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies as regards Mr Beumer's appointment.

 

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Paul Farquhar, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

 

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

 

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and

https://twitter.com/kromekgroup.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABELLFBLLEFBF
Date   Source Headline
28th Feb 201912:55 pmRNSHolding(s) in Company
28th Feb 201912:55 pmRNSHolding(s) in Company
28th Feb 201912:50 pmRNSHolding(s) in Company
26th Feb 201912:56 pmRNSDirector Dealings
26th Feb 20197:00 amRNSNuclear security contract with new OEM customer
25th Feb 20191:02 pmRNSResults of General Meeting and Open Offer and TVR
7th Feb 20197:00 amRNSFirm Placing and Open Offer and Notice of GM
28th Jan 20197:00 amRNSKromek Awarded $58m Medical Imaging Contract
14th Jan 20197:00 amRNSInterim Results
18th Dec 20187:00 amRNSNotice of Results
10th Dec 20187:00 amRNSKromek awarded first biological contract by DARPA
19th Nov 20187:00 amRNSFive-year $7.8m baggage screening contract
1st Oct 20185:12 pmRNSResult of AGM and Directorate Change
27th Sep 20187:00 amRNSKromek awarded $1.8m funding from DTRA
7th Sep 20182:57 pmRNSNotice of AGM and Posting of Annual Report
20th Aug 20187:00 amRNSKromek wins two new contracts in medical division
23rd Jul 20187:00 amRNSKromek secures two contracts from US government
17th Jul 20187:00 amRNSKromek radiation detectors used during NATO Summit
2nd Jul 20187:00 amRNSFinal Results
30th May 20187:00 amRNSFive-year contract from existing medical customer
1st May 20187:00 amRNSTrading Update
23rd Apr 20187:00 amRNSAward of Molecular Breast Imaging Device project
12th Mar 20187:00 amRNSAward of $1.6m extension to contract by DARPA
11th Jan 20187:00 amRNSAppointment of Joint Broker
19th Dec 20177:00 amRNSInterim Results
27th Nov 20177:00 amRNSNotice of Results
31st Oct 20174:13 pmRNSTotal Voting Rights
13th Oct 20177:00 amRNSDirector/PDMR Shareholding
10th Oct 20179:50 amRNSDirector/PDMR Shareholding
26th Sep 201712:12 pmRNSResult of AGM
26th Sep 20177:00 amRNSDirectorate Change
19th Sep 20174:43 pmRNSExercise of Options
4th Sep 20177:00 amRNSNew five-year security screening contract
1st Sep 201710:49 amRNSNotice of AGM and Posting of Annual Report
31st Aug 201710:51 amRNSTotal Voting Rights
17th Aug 20177:00 amRNSAward of Five-Year Contract from BMD Customer
10th Jul 201712:00 pmRNSPublication of Annual Report
28th Jun 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSKromek Radiation Detectors Used During Trump Visit
1st Jun 20171:34 pmRNSTotal Voting Rights
2nd May 201712:23 pmRNSHolding(s) in Company
28th Apr 20177:00 amRNSTrading Update
5th Apr 201712:18 pmRNSBlock listing Interim Review
29th Mar 20177:00 amRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSAward of New Contract for Radiation Detectors
22nd Feb 20177:00 amRNSFive-Year Contract in Security Screening Market
15th Feb 20174:35 pmRNSHolding(s) in Company
15th Feb 201712:54 pmRNSHolding(s) in Company
15th Feb 201712:51 pmRNSHolding(s) in Company
14th Feb 20175:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.